von Czettritz, P., &Meier, A.(2019).
Off-Label Use Reimbursement: A Review of the Status Quo in the Context of the Recent Novartis/AIFA Case.
<em>European Pharmaceutical Law Review, 3</em>(2).
Retrieved from <a href="https://doi.org/10.21552/eplr/2019/2/5">https://doi.org/10.21552/eplr/2019/2/5</a>